Literature DB >> 31854454

Effect of short-term betamethasone administration on the regeneration process of tissue-engineered bone.

Takahiro Chihara1,2, Yiming Zhang1,3, Xianqi Li1,2,4, Atsushi Shinohara1,2,5, Hideaki Kagami1,4,6.   

Abstract

Local inflammation at the transplanted site of tissue-engineered bone may cause apoptosis of the transplanted cells, thus negatively affecting bone regeneration. To maximize the efficacy of bone tissue engineering, the local effect of short-term corticosteroid administration at the transplanted site of tissue-engineered bone was studied with respect to the expression of inflammatory cytokines. Compact bone-derived cells from mouse leg bones were isolated, cultured and seeded onto β-tricalcium phosphate granules. The constructs were transplanted to the back of syngeneic mice. Betamethasone sodium phosphate was administered intraperitoneally to an experimental (betamethasone) group, whereas the same amount of saline was administered to a control group. When betamethasone was administered three times (immediately after operation and 12 hours and 24 hours after transplantation), the number of SP7/osterix-positive osteoblasts was larger in the betamethasone group. Three times of betamethasone administration (immediately after operation and 12 hours and 24 hours after transplantation) did not change the number of apoptotic cells and osteoclasts, but showed a slight upregulation of IL-4 and a downregulation of IL-6. However, 7 doses of betamethasone administration (over 7 consecutive days) increased the number of apoptotic cells and osteoclasts, which was correlated with a downregulation of IL-4 and an upregulation of IL-6. TNF-α expression levels showed no significant differences between the two groups. The results showed beneficial effects of 3 betamethasone administrations for bone regeneration therapy but contrary effects when betamethasone was administered 7 times due to the downregulation of anti-inflammatory cytokines (IL-4) and the upregulation of inflammatory cytokines (IL-6). As a conclusion, our results suggested the importance of the cautious usage of corticosteroids to control local inflammation at transplanted sites in bone tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31854454     DOI: 10.14670/HH-18-193

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  29 in total

Review 1.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

2.  Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate.

Authors:  Bruna Corradetti; Francesca Taraballi; Sebastian Powell; David Sung; Silvia Minardi; Mauro Ferrari; Bradley K Weiner; Ennio Tasciotti
Journal:  Stem Cells Dev       Date:  2015-03-06       Impact factor: 3.272

Review 3.  Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.

Authors:  Emira Ayroldi; Lorenza Cannarile; Graziella Migliorati; Giuseppe Nocentini; Domenico V Delfino; Carlo Riccardi
Journal:  FASEB J       Date:  2012-09-05       Impact factor: 5.191

4.  Short-term effects of corticosteroids on trabecular bone remodeling in old ewes.

Authors:  P Chavassieux; A Buffet; P Vergnaud; P Garnero; P J Meunier
Journal:  Bone       Date:  1997-05       Impact factor: 4.398

5.  Stem cell therapy for reconstruction of alveolar cleft and trauma defects in adults: A randomized controlled, clinical trial.

Authors:  Mona N Bajestan; Archana Rajan; Sean P Edwards; Sharon Aronovich; Lucia H S Cevidanes; Angeliki Polymeri; Suncica Travan; Darnell Kaigler
Journal:  Clin Implant Dent Relat Res       Date:  2017-06-28       Impact factor: 3.932

Review 6.  Specificity and sensitivity of glucocorticoid signaling in health and disease.

Authors:  Derek W Cain; John A Cidlowski
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-04-25       Impact factor: 4.690

7.  Comparisons of mouse mesenchymal stem cells in primary adherent culture of compact bone fragments and whole bone marrow.

Authors:  Yiting Cai; Tianshu Liu; Fang Fang; Chengliang Xiong; Shiliang Shen
Journal:  Stem Cells Int       Date:  2015-03-03       Impact factor: 5.443

8.  Spontaneously Formed Spheroids from Mouse Compact Bone-Derived Cells Retain Highly Potent Stem Cells with Enhanced Differentiation Capability.

Authors:  Kai Chen; Xianqi Li; Ni Li; Hongwei Dong; Yiming Zhang; Michiko Yoshizawa; Hideaki Kagami
Journal:  Stem Cells Int       Date:  2019-05-05       Impact factor: 5.443

Review 9.  Glucocorticoid-induced osteoporosis.

Authors:  Karine Briot; Christian Roux
Journal:  RMD Open       Date:  2015-04-08

10.  Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow-derived counterparts.

Authors:  Daniel Blashki; Matthew B Murphy; Mauro Ferrari; Paul J Simmons; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2016-08-16       Impact factor: 7.813

View more
  1 in total

1.  Effect of TNF-α and IL-6 on Compact Bone-Derived Cells.

Authors:  Yiming Zhang; Xianqi Li; Takahiro Chihara; Hongwei Dong; Hideaki Kagami
Journal:  Tissue Eng Regen Med       Date:  2021-04-13       Impact factor: 4.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.